If you’re a federal employee and have questions about continuing coverage, please speak to your Patient Benefits Specialist and visit our insurance page here: virginiacancerspecialists.com/insurance/.

A monumental step forward in the treatment of non-small cell lung cancer patients harboring a KRAS mutation, Dr. Christina Brzezniak

Lung Cancer Team, Christina Brzezniak, Alex Spira, Lung Cancer, Non-Small Cell Lung Cancer
June 16, 2021
Read More

Alexander I Spira, MD, PhD, FACP - Sotorasib for Lung Cancers with KRAS p.G12C Mutation, The New England Journal of Medicine

Alex Spira, Lung Cancer
June 4, 2021
Read More

Colorectal Cancer Awareness - Keeran Sampat, MD

Colon & Rectal Cancer, Keeran R. Sampat
March 29, 2021
Read More

Mitul Gandhi, MD - Myeloma: Symptoms, Treatment, and the Role of Clinical Trials Event - March 25 2021

Events, Multiple Myeloma, Mitul Gandhi
March 2, 2021
Read More

Exploring Why Testing in Lung Cancer is Important to Treatment Decisions - Alex Spira, MD, PhD, FACP

Alex Spira, Lung Cancer
February 23, 2021
Read More

Virginia Cancer Specialists Joins MYLUNG Consortium, Aiming to Advance Use of Precision Medicine for Metastatic Non-Small Cell Lung Cancer Patients

The Research Institute, Alex Spira, Clinical Trials and Research, Lung Cancer
February 4, 2021
Read More

Register Today! Lung Cancer Event - Dr. Alex Spira, Virginia Cancer specialists:- Wednesday, July 29, 2020 at 5:15 pm EST

Events, Lung Cancer
July 24, 2020
Read More

Sarcoma Strong 5K, August 14th-16th, 2020. Register now, and run/walk wherever you are!

Events, Sarcoma
July 23, 2020
Read More

Interview with Dr. Alex Spira - Medpage Today Lung Cancer and Covid19

Alex Spira, Lung Cancer
June 16, 2020
Read More

Dr. Mitul Gandhi, highlights key abstracts from the #ASCO20 Virtual Scientific Program that aim to improve outcomes for patients with multiple myeloma

Multiple Myeloma, Mitul Gandhi
June 15, 2020
Read More

Award Winning Physicians

Our Physicians work for you, ensuring the highest standard of care.

Learn More
Return to Top